Company intelligence / Profile preview

Arkin Holdings

Herzliya, Tel Aviv District, Israelarkin-capital.com ↗

Ownership: Private
Development stage: Other

Overview

Arkin Holdings is Israel’s largest private healthcare investor with over $2 billion under management. It invests in early to late-stage biotech, pharma, medical device and digital health startups globally. Its funds have backed numerous successful exits and IPOs across multiple therapeutic areas through direct investments and specialized arms like Arkin Bio-Ventures.

Modalities: Small moleculeMonoclonal antibodyGene therapyRNA therapy
Industry: Investors

Partnerships

Phoenix GroupMigdal

Beyond the preview

Go deeper on Arkin Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arkin Holdings.

Explore the full profile